HK Stock MarketDetailed Quotes

ANTENGENE-B (06996)

Watchlist
  • 5.940
  • -0.060-1.00%
Market Closed Apr 17 16:07 CST
4.03BMarket Cap-15.23P/E (TTM)

ANTENGENE-B (06996) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
Sale of pharmaceutical products101.06M95.94%
授权及合作收入4.28M4.06%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Sale of pharmaceutical products101.06M95.94%
授权及合作收入4.28M4.06%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
The mainland of China85.73M81.38%
Other countries / regions19.61M18.62%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More